X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Aventis Pharma with Elder Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANOFI INDIA vs ELDER PHARMA - Comparison Results

SANOFI INDIA     Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SANOFI INDIA ELDER PHARMA SANOFI INDIA/
ELDER PHARMA
 
P/E (TTM) x 35.5 -0.2 - View Chart
P/BV x 6.2 0.1 6,190.8% View Chart
Dividend Yield % 1.4 0.0 -  

Financials

 SANOFI INDIA   ELDER PHARMA
EQUITY SHARE DATA
    SANOFI INDIA
Dec-18
ELDER PHARMA
Jun-14
SANOFI INDIA/
ELDER PHARMA
5-Yr Chart
Click to enlarge
High Rs6,840380 1,800.0%   
Low Rs4,630188 2,462.8%   
Sales per share (Unadj.) Rs1,203.1491.2 244.9%  
Earnings per share (Unadj.) Rs165.3-3.2 -5,194.3%  
Cash flow per share (Unadj.) Rs209.914.4 1,456.5%  
Dividends per share (Unadj.) Rs84.000-  
Dividend yield (eoy) %1.50-  
Book value per share (Unadj.) Rs963.6376.5 255.9%  
Shares outstanding (eoy) m23.0320.54 112.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.80.6 824.4%   
Avg P/E ratio x34.7-89.3 -38.9%  
P/CF ratio (eoy) x27.319.7 138.6%  
Price / Book Value ratio x6.00.8 789.0%  
Dividend payout %50.80-   
Avg Mkt Cap Rs m132,0785,833 2,264.2%   
No. of employees `0003.3NA-   
Total wages/salary Rs m4,0682,179 186.7%   
Avg. sales/employee Rs Th8,393.8NM-  
Avg. wages/employee Rs Th1,232.4NM-  
Avg. net profit/employee Rs Th1,153.0NM-  
INCOME DATA
Net Sales Rs m27,70810,089 274.6%  
Other income Rs m897257 349.6%   
Total revenues Rs m28,60510,346 276.5%   
Gross profit Rs m6,235-792 -787.3%  
Depreciation Rs m1,027361 284.3%   
Interest Rs m72,756 0.3%   
Profit before tax Rs m6,098-3,653 -166.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m03,713 0.0%   
Tax Rs m2,292125 1,831.4%   
Profit after tax Rs m3,806-65 -5,824.0%  
Gross profit margin %22.5-7.8 -286.7%  
Effective tax rate %37.6-3.4 -1,097.1%   
Net profit margin %13.7-0.6 -2,120.7%  
BALANCE SHEET DATA
Current assets Rs m15,9229,240 172.3%   
Current liabilities Rs m6,2359,998 62.4%   
Net working cap to sales %35.0-7.5 -465.5%  
Current ratio x2.60.9 276.3%  
Inventory Days Days6446 137.4%  
Debtors Days Days2160 34.8%  
Net fixed assets Rs m7,53910,124 74.5%   
Share capital Rs m230206 111.8%   
"Free" reserves Rs m21,9625,582 393.4%   
Net worth Rs m22,1927,734 287.0%   
Long term debt Rs m04,889 0.0%   
Total assets Rs m29,83922,882 130.4%  
Interest coverage x872.1-0.3 -268,111.5%   
Debt to equity ratio x00.6 0.0%  
Sales to assets ratio x0.90.4 210.6%   
Return on assets %12.811.8 108.7%  
Return on equity %17.2-0.8 -2,029.6%  
Return on capital %27.522.3 123.3%  
Exports to sales %03.0 0.0%   
Imports to sales %00.4 0.0%   
Exports (fob) Rs mNA307 0.0%   
Imports (cif) Rs mNA43 0.0%   
Fx inflow Rs m7,587307 2,474.6%   
Fx outflow Rs m7,145125 5,702.3%   
Net fx Rs m442181 243.8%   
CASH FLOW
From Operations Rs m3,73911,754 31.8%  
From Investments Rs m-731-561 130.4%  
From Financial Activity Rs m-1,972-6,762 29.2%  
Net Cashflow Rs m1,0364,432 23.4%  

Share Holding

Indian Promoters % 0.0 39.6 -  
Foreign collaborators % 60.4 0.0 -  
Indian inst/Mut Fund % 14.4 7.5 192.0%  
FIIs % 14.6 16.8 86.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 10.5 36.1 29.1%  
Shareholders   15,184 16,479 92.1%  
Pledged promoter(s) holding % 0.0 77.6 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SANOFI INDIA With:   PFIZER  ABBOTT INDIA  PLETHICO PHARMA  WYETH LTD  TORRENT PHARMA  

Compare SANOFI INDIA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Yes Bank's Road Ahead(Podcast)

The stock markets witnessed selling pressure in the week gone by. Market participants remained cautious tracking tepid quarterly earnings amid weak cues.

Related Views on News

SANOFI INDIA Announces Quarterly Results (4QFY19); Net Profit Up 12.6% (Quarterly Result Update)

May 8, 2019 | Updated on May 8, 2019

For the quarter ended March 2019, SANOFI INDIA has posted a net profit of Rs 929 m (up 12.6% YoY). Sales on the other hand came in at Rs 7 bn (up 16.1% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

SANOFI INDIA 2017-18 Annual Report Analysis (Annual Result Update)

Apr 16, 2019 | Updated on Apr 16, 2019

Here's an analysis of the annual report of SANOFI INDIA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of SANOFI INDIA. Also includes updates on the valuation of SANOFI INDIA.

SANOFI INDIA Announces Quarterly Results (3QFY19); Net Profit Up 4.3% (Quarterly Result Update)

Mar 5, 2019 | Updated on Mar 5, 2019

For the quarter ended December 2018, SANOFI INDIA has posted a net profit of Rs 793 m (up 4.3% YoY). Sales on the other hand came in at Rs 7 bn (up 8.4% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

SANOFI INDIA Announces Quarterly Results (2QFY19); Net Profit Up 2.5% (Quarterly Result Update)

Nov 6, 2018 | Updated on Nov 6, 2018

For the quarter ended September 2018, SANOFI INDIA has posted a net profit of Rs 1 bn (up 2.5% YoY). Sales on the other hand came in at Rs 7 bn (up 11.4% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

SANOFI INDIA Announces Quarterly Results (1QFY19); Net Profit Up 35.1% (Quarterly Result Update)

Jul 27, 2018 | Updated on Jul 27, 2018

For the quarter ended June 2018, SANOFI INDIA has posted a net profit of Rs 996 m (up 35.1% YoY). Sales on the other hand came in at Rs 7 bn (up 13.8% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

More Views on News

Most Popular

These 3 Smallcap Stocks are Set to Make the Most of Smallcap Rebound(Profit Hunter)

Jul 9, 2019

As the sense of normalcy returns to the markets, the rebound in the quality smallcaps could be huge.

2 Stocks from Super Investor Sanjay Bakshi's Portfolio You Can Bet On...(The 5 Minute Wrapup)

Jul 12, 2019

Despite the current fear prevailing in the markets, both these stocks have the potential to deliver in 4-5 years.

After Disappointing Budget, Here's a Document that Concerns Largecap and Smallcap Investors(The 5 Minute Wrapup)

Jul 8, 2019

A new 'definition' of the stock universe that triggered the smallcap sell-off is back with the latest list...

Here's What to Do with Falling Small Cap Stocks(Profit Hunter)

Jul 10, 2019

There are some great buying opportunities in the market right now - and the small cap space is your best bet.

Budget an Icing on the Cake for This Smart Money Backed Affordable Housing Stock(The 5 Minute Wrapup)

Jul 10, 2019

Affordable housing is one of the most straightforward growth stories in India. This will help the real estate sector to come out of the slump.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

SANOFI INDIA SHARE PRICE


Jul 19, 2019 (Close)

TRACK SANOFI INDIA

  • Track your investment in SANOFI INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SANOFI INDIA - STRIDES PHARMA SCIENCE COMPARISON

COMPARE SANOFI INDIA WITH

MARKET STATS